Four Launches From 100: Rocket Lab Gets a Bullish New Call, With Iridium and Mynaric Along for the Ride
Rocket Lab (RKLB) completed its 16th Electron mission of 2026, nearing an annual launch record. Raymond James initiated coverage with an Outperform rating and $80 price target, citing growth from Neutron rocket, Mynaric acquisition, and pending Iridium (IRDM) deal. Analyst projects positive EBITDA by 2027-2028, but notes execution risks.
How this was made

The 30-second read
Why it matters
Analyst upgrade and large acquisition signal growth but introduce execution risk.
Market read
New coverage and a major pending acquisition provide fresh catalysts for RKLB and IRDM, affecting the broader space‑tech sector.
What to watch
Potential delays in Neutron development and margin assumptions may limit near‑term gains.
Background
Rocket Lab recently completed its 16th Electron mission of 2026 and is nearing its annual launch record.
Ticker impact
Raymond James initiated coverage with an Outperform rating and $80 price target, a fresh analyst upgrade for Rocket Lab.
Potential 20‑30% upside over the next weeks.
New coverage and price target provide a concrete catalyst; execution risk remains.
Rocket Lab's pending $8 billion acquisition of Iridium Communications is highlighted as a major upside driver.
IRDM may see modest upside if acquisition clears, but volatility expected.
Acquisition size is large; approval uncertainty tempers impact.
Market effects
Boosts outlook for small‑sat launch and satellite‑service sector.
Positive for US space‑tech equities; limited effect elsewhere.
Highlights consolidation trend in commercial space industry.
Counterpoint
Execution and integration risks could outweigh upside, leading to price disappointment.
Key entities
- companyRocket Lab Corporation
US‑listed space launch provider (NASDAQ:RKLB).
- companyIridium Communications Inc.
US‑listed satellite communications firm (NASDAQ:IRDM).


